A review of biotransformation and pharmacology of ginsenoside compound K

Fitoterapia

Volumn 100, Issue , 2015, Pages 208-220

  Yang, Xi Ding ^a,b   Yang, Yong Yu ^b   Ouyang, Dong Sheng ^b   Yang, Guo Ping ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biotransformation; Ginseng; Ginsenoside compound K; Pharmacological activities

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIALLERGIC AGENT; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; BETA GLUCOSIDASE; COMPOUND K; DRUG METABOLITE; GINSENOSIDE; UNCLASSIFIED DRUG; GINSENOSIDE M1;

ANTIANGIOGENIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL INVASION; CENTRAL NERVOUS SYSTEM; COGNITION; DRUG CYTOTOXICITY; DRUG TRANSFORMATION; HUMAN; INTESTINE FLORA; LIVER PROTECTION; METASTASIS; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; BIOTRANSFORMATION; METABOLISM;

BACTERIA (MICROORGANISMS); PANAX GINSENG;

BIOTRANSFORMATION; GINSENOSIDES;

EID: 84921027428     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2014.11.019     Document Type: Review

References (101)

1. TK Yun Panax ginseng - a non-organ-specific cancer preventive? Lancet Oncol 2 1 2001 49 55
2. LP Christensen Ginsenosides chemistry, biosynthesis, analysis, and potential health effects Adv Food Nutr Res 55 2009 1 99
3. J Shi, W Xue, WJ Zhao, and KX Li Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats Acta Pharmacol Sin 34 2 2013 214 220
4. J Sun, X Song, and S Hu Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice Clin Vaccine Immunol 15 2 2008 303 307
5. M Mochizuki, YC Yoo, K Matsuzawa, K Sato, I Saiki, and S Tono-Oka Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng Biol Pharm Bull 18 9 1995 1197 1202
6. MA Tawab, U Bahr, M Karas, M Wurglics, and M Schubert-Zsilavecz Degradation of ginsenosides in humans after oral administration Drug Metab Dispos 31 8 2003 1065 1071
7. Y.W. Shin, and D.H. Kim Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models J Pharmacol Sci 99 1 2005 83 88
8. K. Kim, M. Park, Y.M. Lee, M.R. Rhyu, and H.Y. Kim Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation Arch Pharm Res 37 9 2014 1193 1200
9. W Zhou, MQ Feng, JY Li, and P Zhou Studies on the preparation, crystal structure and bioactivity of ginsenoside compound K J Asian Nat Prod Res 8 6 2006 519 527
10. Z Zhang, GJ Du, CZ Wang, XD Wen, T Calway, and Z Li Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions Int J Mol Sci 14 2 2013 2980 2995
11. EH Joh, IA Lee, IH Jung, and DH Kim Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation Biochem Pharmacol 82 3 2011 278 286
12. J Chen, H Wu, Q Wang, Y Chang, K Liu, and S Song Ginsenoside metabolite compound K alleviates adjuvant-induced arthritis by suppressing T cell activation Inflammation 37 5 2014 1608 1615
13. S Kim, BY Kang, SY Cho, DS Sung, HK Chang, and MH Yeom Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin Biochem Biophys Res Commun 316 2 2004 348 355
14. HU Lee, EA Bae, MJ Han, NJ Kim, and DH Kim Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury Liver Int 25 5 2005 1069 1073
15. I Yosioka, T Sugawara, K Imai, and I Kitagawa Soil bacterial hydrolysis leading to genuine aglycone. V. On ginsenosides Rbl, Rb2 and Rc of theginseng root saponins Chem Pharm Bull (Tokyo) 20 11 1972 2418 2421
16. M Karikura, T Miyase, H Tanizawa, T Taniyama, and Y Takino Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats Chem Pharm Bull (Tokyo) 39 9 1991 2357 2361
17. M Karikura, T Miyase, H Tanizawa, Y Takino, T Taniyama, and T Hayashi Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats Chem Pharm Bull (Tokyo) 38 10 1990 2859 2861
18. H Hasegawa, JH Sung, S Matsumiya, and M Uchiyama Main ginseng saponin metabolites formed by intestinal bacteria Planta Med 62 5 1996 453 457
19. H. Hasegawa, J.H. Sung, and Y. Benno Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins Planta Med 63 5 1997 436 440
20. T. Akao, M. Kanaoka, and K. Kobashi Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay Biol Pharm Bull 21 3 1998 245 249
21. T Akao, H Kida, M Kanaoka, M Hattori, and K Kobashi Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng J Pharm Pharmacol 50 10 1998 1155 1160
22. C Wakabayashi, H Hasegawa, J Murata, and I Saiki In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration Oncol Res 9 8 1997 411 417
23. EA Bae, MK Choo, EK Park, SY Park, HY Shin, and D.H. Kim Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity Biol Pharm Bull 25 6 2002 743 747
24. C Wakabayashi, K Murakami, H Hasegawa, J Murata, and I Saiki An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells Biochem Biophys Res Commun 246 3 1998 725 730
25. SJ Lee, JH Sung, SJ Lee, CK Moon, and BH Lee Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin Cancer Lett 144 1 1999 39 43
26. H Yu, C Zhang, M Lu, F Sun, Y Fu, and F Jin Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I Chem Pharm Bull (Tokyo) 55 2 2007 231 235
27. E.A. Bae, JE Shin, and DH Kim Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect Biol Pharm Bull 28 10 2005 1903 1908
28. WY Kim, JM Kim, SB Han, SK Lee, ND Kim, and MK Park Steaming of ginseng at high temperature enhances biological activity J Nat Prod 63 12 2000 1702 1704
29. BH Han, MH Park, YN Han, LK Woo, U Sankawa, and S Yahara Degradation of ginseng saponins under mild acidic conditions Planta Med 44 3 1982 146 149
30. L Y, Kj H, Y Y. A preparation method of less polar individual ginsenosides and saponins by base hydrolysisCN03134090.3[P].
31. EA Bae, SY Park, and DH Kim Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria Biol Pharm Bull 23 12 2000 1481 1485
32. Q Yan, XW Zhou, W Zhou, XW Li, MQ Feng, and P Zhou Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces bainier J Microbiol Biotechnol 18 6 2008 1081 1089
33. YS Keum, KK Park, JM Lee, KS Chun, JH Park, and SK Lee Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng Cancer Lett 150 1 2000 41 48
34. X Zhao, J Wang, J Li, L Fu, J Gao, J Gao, and X Du Highly selective biotransformation of ginsenoside Rb1 to Rd by the phytopathogenic fungus Cladosporium fulvum (syn. Fulvia fulva) J Ind Microbiol Biotechnol 36 5 2009 721 726
35. SY Park, EA Bae, JH Sung, SK Lee, and DH Kim Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium Biosci Biotechnol Biochem 65 5 2001 1163 1169
36. DS An, CH Cui, HG Lee, L Wang, SC Kim, and ST Lee Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV Appl Environ Microbiol 76 17 2010 5827 5836
37. LH Quan, JW Min, Y Jin, C Wang, YJ Kim, and DC Yang Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant beta-glucosidase from Microbacterium esteraromaticum J Agric Food Chem 60 14 2012 3776 3781
38. KH Chang, MN Jo, KT Kim, and HD Paik Evaluation of glucosidases of Aspergillus niger strain comparing with other glucosidases in transformation of ginsenoside Rb1 to ginsenosides Rg3 J Ginseng Res 38 1 2014 47 51
39. KH Noh, JW Son, HJ Kim, and DK Oh Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus Biosci Biotechnol Biochem 73 2 2009 316 321
40. K.H. Noh, and D.K. Oh Production of the rare ginsenosides compound K, compound Y, and compound Mc by a thermostable beta-glycosidase from Sulfolobus acidocaldarius Biol Pharm Bull 32 11 2009 1830 1835
41. LH Quan, Y Jin, C Wang, JW Min, YJ Kim, and DC Yang Enzymatic transformation of the major ginsenoside Rb2 to minor compound Y and compound K by a ginsenoside-hydrolyzing beta-glycosidase from Microbacterium esteraromaticum J Ind Microbiol Biotechnol 39 10 2012 1557 1562
42. MH Yoo, SJ Yeom, CS Park, KW Lee, and DK Oh Production of aglycon protopanaxadiol via compound K by a thermostable beta-glycosidase from Pyrococcus furiosus Appl Microbiol Biotechnol 89 4 2011 1019 1028
43. SR Ko, Y Suzuki, K Suzuki, KJ Choi, and BG. Cho Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method Chem Pharm Bull (Tokyo) 55 10 2007 1522 1527
44. BH Kim, SY Lee, HJ Cho, SN You, YJ Kim, and YM Park Biotransformation of Korean Panax ginseng by Pectinex Biol Pharm Bull 29 12 2006 2472 2478
45. LQ, Cheng, MK Kim, JW Lee, YJ Lee, and DC Yang Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia Biotechnol Lett 28 14 2006 1121 1127
46. Y Han, B Sun, X Hu, H Zhang, B Jiang, and MI Spranger Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng J Agric Food Chem 55 23 2007 9373 9379
47. GT Chen, M Yang, Y Song, ZQ Lu, JQ Zhang, and HL Huang Microbial transformation of ginsenoside Rb(1) by Acremonium strictum Appl Microbiol Biotechnol 77 6 2008 1345 1350
48. LH Quan, YJ Kim, GH Li, KT Choi, and DC Yang Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius World J Microbiol Biotechnol 29 6 2013 1001 1007
49. KA Kim, IH Jung, SH Park, YT Ahn, CS Huh, and DH. Kim Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K PLoS One 8 4 2013 e62409
50. W Zhou, Q Yan, JY Li, XC Zhang, and P Zhou Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229 J Appl Microbiol 104 3 2008 699 706
51. H Chi, and G.E. Ji Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms Biotechnol Lett 27 11 2005 765 771
52. Y Yang, Y Wang, M Yan, C Sun, and P Zheng Screening of plant pathogenic fungi by ginsenoside compound K production Zhong guo Zhong Yao Za Zhi 36 12 2011 1596 1598
53. H Chi, DH Kim, and GE Ji Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms Biol Pharm Bull 28 11 2005 2102 2105
54. LH Quan, JY Piao, JW Min, HB Kim, SR Kim, and DU Yang Biotransformation of ginsenoside Rb1 to prosapogenins, gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by Leuconostoc mesenteroides DC102 J Ginseng Res 35 3 2011 344 351
55. LH Quan, JY Piao, JW Min, DU Yang, HN Lee, and DC Yang Bioconversion of ginsenoside rb1 into compound k by Leuconostoc citreum LH1 isolated from kimchi Braz J Microbiol 42 3 2011 1227 1237
56. X Yan, Y Fan, W Wei, P Wang, Q Liu, and Y. Wei Production of bioactive ginsenoside compound K in metabolically engineered yeast Cell Res 24 6 2014 770 773
57. ES Lee, JS Choi, MS Kim, HJ You, GE Ji, and YH Kang Ginsenoside metabolite compound K differentially antagonizing tumor necrosis factor-alpha-induced monocyte-endothelial trafficking Chem Biol Interact 194 1 2011 13 22
58. SH Yoon, EJ Han, JH Sung, and SH Chung Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice Biol Pharm Bull 30 11 2007 2196 2200
59. Y Chen, Y Xu, Y Zhu, and X. Li Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells Cancer Cell Int 13 1 2013 24
60. CZ Wang, GJ Du, Z Zhang, XD Wen, T Calway, and Z Zhen Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer Int J Oncol 40 6 2012 1970 1976
61. IK Lee, KA Kang, CM Lim, KC Kim, HS Kim, and DH Kim Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells Int J Mol Sci 11 12 2010 4916 4931
62. DY Kim, MW Park, HD Yuan, HJ Lee, SH Kim, and SH Chung Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells J Agric Food Chem 57 22 2009 10573 10578
63. CK Law, HH Kwok, PY Poon, CC Lau, ZH Jiang, and WC Tai Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor Chin Med 9 1 2014 11
64. S Chae, KA Kang, WY Chang, MJ Kim, SJ Lee, and YS Lee Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo J Agric Food Chem 57 13 2009 5777 5782
65. S.H. Oh, and B.H. Lee A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage Toxicol Appl Pharmacol 194 3 2004 221 229
66. YL Ming, G Song, LH Chen, ZZ Zheng, ZY Chen, and GL Ouyang Anti-proliferation and apoptosis induced by a novel intestinal metabolite of ginseng saponin in human hepatocellular carcinoma cells Cell Biol Int 31 10 2007 1265 1273
67. C Hu, G Song, B Zhang, Z Liu, R Chen, and H Zhang Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway J Cell Mol Med 16 1 2012 96 106
68. KA Kang, YW Kim, SU Kim, S Chae, YS Koh, and HS Kim G1 phase arrest of the cell cycle by a ginseng metabolite, compound K, in U937 human monocytic leukamia cells Arch Pharm Res 28 6 2005 685 690
69. K Shinkai, H Akedo, M Mukai, F Imamura, A Isoai, and M Kobayashi Inhibition of in vitro tumor cell invasion by ginsenoside Rg3 Jpn J Cancer Res 87 4 1996 357 362
70. I Saiki, J Murata, M Nakajima, S Tokura, and I. Azuma Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells Cancer Res 50 12 1990 3631 3637
71. Y Ming, Z Chen, L Chen, D Lin, Q Tong, and Z Zheng Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-kappaB p65 and reduction of matrix metalloproteinase-2/9 Planta Med 77 5 2011 428 433
72. SH Jung, MS Woo, SY Kim, WK Kim, JW Hyun, and EJ Kim Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells Int J Cancer 118 2 2006 490 497
73. EK Park, YW Shin, HU Lee, SS Kim, YC Lee, and BY Lee Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide Biol Pharm Bull 28 4 2005 652 656
74. CS Yang, SR Ko, BG Cho, DM Shin, JM Yuk, and S Li The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock J Cell Mol Med 12 5A 2008 1739 1753
75. TT Cuong, CS Yang, JM Yuk, HM Lee, SR Ko, and BG Cho Glucocorticoid receptor agonist compound K regulates Dectin-1-dependent inflammatory signaling through inhibition of reactive oxygen species Life Sci 85 17-18 2009 625 633
76. JS Park, JA Shin, JS Jung, JW Hyun, TK Van Le, and DH Kim Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice J Pharmacol Exp Ther 341 1 2012 59 67
77. JY Lee, JW Shin, KS Chun, KK Park, WY Chung, and YJ Bang Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin Carcinogenesis 26 2 2005 359 367
78. J Li, W Zhong, W Wang, S Hu, J Yuan, and B Zhang Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-kappaB activation PLoS One 9 2 2014 e87810
79. MK Choo, EK Park, MJ Han, and DH Kim Antiallergic activity of ginseng and its ginsenosides Planta Med 69 6 2003 518 522
80. H Wu, J Chen, Q Wang, X Jia, S Song, and P Yuan Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats Immunopharmacol Immunotoxicol 36 2 2014 124 129
81. KK Liu, QT Wang, SM Yang, JY Chen, HX Wu, and W Wei Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis Acta Pharmacol Sin 35 5 2014 599 612
82. YS Choi, EH Kang, EY Lee, HS Gong, HS Kang, and K Shin Joint-protective effects of compound K, a major ginsenoside metabolite, in rheumatoid arthritis: in vitro evidence Rheumatol Int 33 8 2013 1981 1990
83. GC Han, SK Ko, JH Sung, and SH Chung Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice J Agric Food Chem 55 26 2007 10641 10648
84. YC Huang, CY Lin, SF Huang, HC Lin, WL Chang, and TC Chang Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3 T3-L1 adipocytes J Agric Food Chem 58 10 2010 6039 6047
85. DY Kim, HD Yuan, IK Chung, and SH Chung Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells J Agric Food Chem 57 4 2009 1532 1537
86. W Li, M Zhang, J Gu, ZJ Meng, LC Zhao, and YN Zheng Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis Fitoterapia 83 1 2012 192 198
87. HD Yuan, SJ Kim, and SH Chung Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol-3 kinase pathways Metabolism 60 1 2011 43 51
88. K. Kim, DH Kim, and HY Kim Compound K protects MIN6N8 pancreatic beta-cells against palmitate-induced apoptosis through modulating SAPK/JNK activation Cell Biol Int 34 1 2010 75 80
89. PL Brubaker Minireview: update on incretin biology: focus on glucagon-like peptide-1 Endocrinology 151 5 2010 1984 1989
90. C Tohda, N Matsumoto, K Zou, MR Meselhy, and K. Komatsu Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1 A metabolite of protopanaxadiol-type saponins, Neuropsychopharmacology 29 5 2004 860 868
91. JG Hou, JJ Xue, MR Lee, MQ Sun, XH Zhao, and YN Zheng Compound K is able to ameliorate the impaired cognitive function and hippocampal neurogenesis following chemotherapy treatment Biochem Biophys Res Commun 436 1 2013 104 109
92. N. Yamada, H. Araki, and H. Yoshimura Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors Psychopharmacology (Berl) 216 4 2011 589 599
93. JS Park, EM Park, DH Kim, K Jung, JS Jung, and EJ Lee Anti-inflammatory mechanism of ginseng saponins in activated microglia J Neuroimmunol 209 1-2 2009 40 49
94. K Choi, M Kim, J Ryu, and C. Choi Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells Neurosci Lett 421 1 2007 37 41
95. MY Bae, JH Cho, IS Choi, HM Park, MG Lee, and DH Kim Compound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons J Neurochem 114 4 2010 1085 1096
96. S Jang, JH Ryu, DH Kim, and S. Oh Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides Neurochem Res 29 12 2004 2257 2266
97. BH Lee, SH Hwang, SH Choi, HJ Kim, JH Lee, and SM Lee Inhibitory effects of ginsenoside metabolites, compound K and protopanaxatriol, on GABAC receptor-mediated ion currents Korean J Physiol Pharmacol 17 2 2013 127 132
98. A Jeong, HJ Lee, SJ Jeong, HJ Lee, EO Lee, and H Bae Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells Biol Pharm Bull 33 6 2010 945 950
99. KO Shin, CH Seo, HH Cho, S Oh, SP Hong, and HS Yoo Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells Arch Pharm Res 37 9 2014 1183 1192
100. D Park, and M. Yoon Compound K, a novel ginsenoside metabolite, inhibits adipocyte differentiation in 3 T3-L1 cells: involvement of angiogenesis and MMPs Biochem Biophys Res Commun 422 2 2012 263 267
101. D He, J Sun, X Zhu, S Nian, and J Liu Compound K increases type I procollagen level and decreases matrix metalloproteinase-1 activity and level in ultraviolet-A-irradiated fibroblasts J Formos Med Assoc 110 3 2011 153 160